Advertisement

The Latest

Carlsmed raised $30 million in series B funding to ramp up commercialization of its personalized spine implants, the devicemaker said April 19.

Englewood (N.J.) Health named its chief of neurosurgery and three other updates that took place in the last 30 days:

Accelus, a minimally invasive spine device company, and CHP Merger Corp., a special purpose acquisition company, have terminated a previously agreed-upon merger of the companies because of market conditions.

Advertisement